Cargando…

An appropriate response to SARS

Detalles Bibliográficos
Autor principal:	The Lancet Infectious Diseases
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2003
Materias:	Leading Edge
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128109/ https://www.ncbi.nlm.nih.gov/pubmed/12726954 http://dx.doi.org/10.1016/S1473-3099(03)00619-4

Ejemplares similares

Trade in wild animals: a disaster ignored
por: The Lancet Infectious Diseases
Publicado: (2003)

A European CDC
por: The Lancet Infectious Diseases
Publicado: (2003)

Making our hospitals healthier places
por: The Lancet Infectious Diseases
Publicado: (2004)

Original research in The Lancet Infectious Diseases
por: The Lancet Infectious Diseases
Publicado: (2010)

Are you ready for the next influenza pandemic?
por: The Lancet Infectious Diseases
Publicado: (2005)

A new public health world order
por: The Lancet Infectious Diseases
Publicado: (2004)

The use of chromoendoscopy for surveillance of inflammatory bowel disease
por: Lichtenstein, Gary R., et al.
Publicado: (2018)

Precision Medicine: Solving the Mystery of Myocarditis in the Aftermath of SARS-CoV-2
por: Feldman, Arthur M., et al.
Publicado: (2023)

Are anticoagulants still indicated in pulmonary arterial hypertension?
por: Olschewski, Horst, et al.
Publicado: (2018)

Early intervention: should we conduct therapeutic trials for mild pulmonary hypertension before onset of symptoms?
por: Huston, Jessica H., et al.
Publicado: (2019)

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
por: Elliott, C. Gregory, et al.
Publicado: (2019)

Extracellular vesicles released from p18 overexpressing pulmonary endothelial cells are barrier protective – potential implications for acute respiratory distress syndrome
por: Harrington, Elizabeth O., et al.
Publicado: (2020)

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020)

Transplanting COVID-19–Positive Donor Hearts: A Previous Threat, Now an Opportunity
por: Schlendorf, Kelly H., et al.
Publicado: (2023)

Cardiac Pericytes: Underappreciated Targets of SARS-CoV-2
por: Das, Mitali, et al.
Publicado: (2023)

Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection
por: Brumback, Brittany D., et al.
Publicado: (2022)

The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

Reflections on SARS
por: The Lancet Infectious Diseases
Publicado: (2004)

Frontline Science: Shh production and Gli signaling is activated in vivo in lung, enhancing the Th2 response during a murine model of allergic asthma
por: Standing, Ariane S. I., et al.
Publicado: (2017)

Frontline Science: TNF‐α and GM‐CSF1 priming augments the role of SOS1/2 in driving activation of Ras, PI3K‐γ, and neutrophil proinflammatory responses
por: Suire, Sabine, et al.
Publicado: (2019)

Emerging SARS-CoV-2 variants: shooting the messenger
por: The Lancet Infectious Diseases
Publicado: (2022)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

“In an ocean of ashes, islands of order”: WHO's SARS-CoV-2 origin report
por: The Lancet Infectious Diseases
Publicado: (2021)

A proportionate response to H7N9
por: The Lancet Infectious Diseases
Publicado: (2013)

TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation
por: McGrath, Emmet E., et al.
Publicado: (2011)

Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β
por: Willet, Joseph D. P., et al.
Publicado: (2013)

Analysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediators
por: Raza, Sobia, et al.
Publicado: (2014)

Langerin-expressing dendritic cells in human tissues are related to CD1c(+) dendritic cells and distinct from Langerhans cells and CD141(high) XCR1(+) dendritic cells
por: Bigley, Venetia, et al.
Publicado: (2015)

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure
por: Byrne, Nikole J., et al.
Publicado: (2017)

Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms
por: Petri, Marcelo H., et al.
Publicado: (2018)

Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis
por: Teague, Heather L., et al.
Publicado: (2019)

IL‐4 induces a suppressive IL‐10‐producing CD8(+) T cell population via a Cdkn2a‐dependent mechanism
por: Zhao, Yapu, et al.
Publicado: (2013)

Frontline Science: Employing enzymatic treatment options for management of ocular biofilm‐based infections
por: Kugadas, Abirami, et al.
Publicado: (2019)

Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis
por: Bowler, Meghan A., et al.
Publicado: (2019)

Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
por: Verma, Subodh, et al.
Publicado: (2018)

On Our Doorstep, A Precious Cargo From MSCs: The Role of Extracellular Vesicles in Stem Cell Therapy
por: Cooke, John P.
Publicado: (2020)

Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal Cells
por: Wang, Liyong, et al.
Publicado: (2020)

Frontline Science: Endotoxin‐induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst
por: Grondman, Inge, et al.
Publicado: (2019)

Frontline Science: Antagonism between regular and atypical Cxcr3 receptors regulates macrophage migration during infection and injury in zebrafish
por: Sommer, Frida, et al.
Publicado: (2019)

Integrating Integrins: A New Way to Increase Our COVID-19 Armamentarium?
por: Ross, Robert S.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0084s84odejb39fqepo5fojs3